Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

10.93
-0.2100-1.89%
Post-market: 10.930.00000.00%19:30 EDT
Volume:199.42K
Turnover:2.21M
Market Cap:534.32M
PE:-3.41
High:11.60
Open:11.26
Low:10.76
Close:11.14
52wk High:14.53
52wk Low:2.22
Shares:48.89M
Float Shares:19.90M
Volume Ratio:0.63
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2084
EPS(LYR):-3.4309
ROE:-36.58%
ROA:-22.34%
PB:1.54
PE(LYR):-3.19

Loading ...

Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development

GlobeNewswire
·
May 19

RA Capital Management reports Artiva Biotherapeutics share buy worth $75 million

Reuters
·
May 14

Artiva Biotherapeutics price target raised to $41 from $18 at Needham

TIPRANKS
·
May 13

Needham Remains a Buy on Artiva Biotherapeutics, Inc. (ARTV)

TIPRANKS
·
May 12

Artiva Biotherapeutics Is Maintained at Outperform by Wedbush

Dow Jones
·
May 11

Cantor Fitzgerald Remains a Buy on Artiva Biotherapeutics, Inc. (ARTV)

TIPRANKS
·
May 11

Artiva Biotherapeutics Inc : Wedbush Raises Target Price to $40 From $23

THOMSON REUTERS
·
May 11

Tyler Van Buren Reiterates Buy on Artiva, Citing Strong AlloNK RA Efficacy and Funded Path to Registrational Trial

TIPRANKS
·
May 11

U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla

Reuters
·
May 11

Artiva Biotherapeutics price target raised to $35 from $15 at H.C. Wainwright

TIPRANKS
·
May 09

Artiva Biotherapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 09

BUZZ-U.S. STOCKS ON THE MOVE-Corning, Moderna, News Corp

Reuters
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Coinbase, Microchip, Wendy's

Reuters
·
May 08

Sector Update: Healthcare Stocks Steady Pre-Bell Friday

MT Newswires Live
·
May 08

Wedbush Adjusts Price Target on Artiva Biotherapeutics to $40 From $23, Maintains Outperform Rating

MT Newswires Live
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Cloudflare, IREN, Monster Beverage

Reuters
·
May 08

Artiva Biotherapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Top Premarket Gainers

MT Newswires Live
·
May 08

Artiva Biotherapeutics Prices $300 Million Shares, Warrants Offering

MT Newswires Live
·
May 08

Artiva Biotherapeutics Posts Positive Early Data for AlloNK Rheumatoid Arthritis Treatment

MT Newswires Live
·
May 08